Association of LIPC -250G>A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations
详细信息 查看全文
- 作者：Li Meng (1)
Yin Ruixing (1)
Li Yiyang (1)
Long Xingjiang (1)
Li Kela (1)
Liu Wanying (1)
Zhang Lin (1)
Lin Weixiong (2)
Yang Dezhai (2)
Pan Shangling (3) - 刊名：Lipids in Health and Disease
- 出版年：2010
- 出版时间：December 2010
- 年：2010
- 卷：9
- 期：1
- 全文大小：1175KB
- 参考文献：1. Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, Raynor WJ Jr: Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. / N Engl J Med 1981, 304:65鈥?0. CrossRef
2. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive Summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). / JAMA 2001, 285:2486鈥?7. CrossRef
3. Satoh H, Nishino T, Tomita K, Tsutsui H: Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men: Results from a 10-year cohort study. / Circ J 2006, 70:227鈥?1. CrossRef
4. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F: Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. / Circulation 1998, 97:1029鈥?6.
5. Achari V, Thakur AK: Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis. / J Assoc Physicians India 2004, 52:103鈥?.
6. M盲rz W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR: Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. / Circulation 2004, 110:3068鈥?4. CrossRef
7. Kwiterovich PO Jr, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA: Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. / Am J Cardiol 1992, 69:1015鈥?1. CrossRef
8. Durrington PN, Hunt L, Ishola M, Kane J, Stephens WP: Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. / Br Heart J 1986, 56:206鈥?2. CrossRef
9. Boden WE: High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: Assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trail. / Am J Cardiol 2000, 86:19L-22L. CrossRef
10. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA: High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. / Circulation 1989, 79:8鈥?5.
11. Ruixing Y, Yuming C, Shangling P, Fengping H, Tangwei L, Dezhai Y, Jinzhen W, Limei Y, Weixiong L, Rongshan L, Jiandong H: Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. / Eur J Cardiovasc Prev Rehabil 2006, 13:977鈥?4. CrossRef
12. Mann JI: Dietary effects on plasma LDL and HDL. / Curr Opin Lipidol 1997, 8:35鈥?. CrossRef
13. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R: Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. / Am J 1987, 126:629鈥?7.
14. Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: An analysis of published data. / BMJ 1989, 298:784鈥?. CrossRef
15. Berns MA, de Vries JH, Katan MB: Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. / Am J Epidemiol 1989, 130:1109鈥?2.
16. Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD: Blood lipid and lipoprotein adaptations to exercise: A quantitative analysis. / Sports Med 2001, 31:1033鈥?2. CrossRef
17. Ruixing Y, Jinzhen W, Weixiong L, Yuming C, Dezhai Y, Shangling P: The environmental and genetic evidence for the association of hyperlipidemia and hypertension. / J Hypertens 2009, 27:251鈥?. CrossRef
18. Heller DA, de Faire U, Pedersen NL, Dahl茅n G, McClearn GE: Genetic and environmental influences on serum lipid levels in twins. / N Engl J Med 1993, 328:1150鈥?. CrossRef
19. Steinmetz J, Boerwinkle E, Gueguen R, Visvikis S, Henny J, Siest G: Multivariate genetic analysis of high density lipoprotein particles. / Atherosclerosis 1992, 92:219鈥?7. CrossRef
20. P茅russe L, Rice T, Despr茅s JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. / Arterioscler Thromb Vasc Biol 1997, 17:3263鈥?.
21. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD: Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. / Arterioscler Thromb 1993, 13:147鈥?3.
22. Santamarina-Fojo S, Haudenschild C, Amar M: The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. / Curr Opin Lipidol 1998, 9:211鈥?. CrossRef
23. Kuusi T, Saarinen P, Nikkil盲 EA: Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. / Atherosclerosis 1980, 36:589鈥?3. CrossRef
24. Salonen JT, Salonen R, Sepp盲nen K, Rauramaa R, Tuomilehto J: HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. / Circulation 1991, 84:129鈥?9.
25. Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despr茅s JP: Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Qu茅bec Cardiovascular Study. / Arterioscler Thromb Vasc Biol 1997, 17:1098鈥?05.
26. Eller P, Schgoer W, Mueller T, Tancevski I, Wehinger A, Ulmer H, Foeger B, Haltmayer M, Ritsch A, Patsch JR: Hepatic lipase polymorphism and increased risk of peripheral arterial disease. / J Intern Med 2005, 258:344鈥?. CrossRef
27. Cai SJ, Wong DM, Chen SH, Chan L: Structure of the human hepatic triglyceride lipase gene. / Biochemistry 1989, 28:8966鈥?1. CrossRef
28. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Buscher M, Schotz MC, Will H: Isolation and characterization of the human hepatic lipase gene. / J Biol Chem 1990, 265:6552鈥?.
29. van't Hooft FM, Lundahl B, Ragogna F, Karpe F, Olivecrona G, Hamsten A: Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. / Arterioscler Thromb Vasc Biol 2000, 20:1335鈥?.
30. Juo SH, Han Z, Smith JD, Colangelo L, Liu K: Promoter polymorphisms of hepatic lipase gene influence HDL2 but not HDL3 in African American men: CARDIA study. / J Lipid Res 2001, 42:258鈥?4.
31. Bertolini S, Pisciotta L, Di Scala L, Langheim S, Bellocchio A, Masturzo P, Cantafora A, Martini S, Averna M, Pes G, Stefanutti C, Calandra S: Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. / Atherosclerosis 2004, 174:57鈥?5. CrossRef
32. Jim茅nez-G贸mez Y, P茅rez-Jim茅nez F, Mar铆n C, G贸mez P, Moreno R, Delgado J, P茅rez-Mart铆nez P, G贸mez MJ, L贸pez-Miranda J: The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men. / Nutr Metab Cardiovasc Dis 2008, 18:173鈥?1. CrossRef
33. Ko YL, Hsu LA, Hsu KH, Ko YH, Lee YS: The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. / Atherosclerosis 2004, 172:135鈥?2. CrossRef
34. Lindi V, Schwab U, Louheranta A, Vessby B, Hermansen K, Tapsell L, Riccardi G, Rivellese AA, Laakso M, Uusitupa MI, KANWU Study Group: The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study. / Nutr Metab Cardiovasc Dis 2008, 18:88鈥?5. CrossRef
35. Pihlajamaki J, Karjalainen L, Karhapaa P, Vauhkonen I, Taskinen MR, Deeb SS, Laakso M: G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. / Arterioscler Thromb Vasc Biol 2000, 20:1789鈥?5.
36. Stancakova A, Baldaufova L, Javorsky M, Kozarova M, Salagovic J, Tkac I: Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. / Physiol Res 2006, 55:483鈥?0.
37. Wood KC, Fullerton MD, El-Sohemy A, Bakovic M: Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults. / Appl Physiol Nutr Metab 2008, 33:761鈥?. CrossRef
38. Zhao S, Xie X, Nie S: The -250G/A polymorphism in the human hepatic lipase gene promoter affects blood lipids in Chinese. / Clin Chim Acta 2006, 365:149鈥?2. CrossRef
39. de Andrade FM, Silveira FR, Arsand M, Antunes AL, Torres MR, Zago AJ, Callegari-Jaques SM, Hutz MH: Association between -250G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian population. / Clin Genet 2004, 65:390鈥?. CrossRef
40. Wei M, Lu Y, Li P: Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease. / Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009, 26:219鈥?2.
41. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD: Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. / Arterioscler Thromb Vasc Biol 1998, 18:1723鈥?.
42. Tahvanainen E, Syvanne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, Kauma H, Pasternak A, Taskinen MR, Ehnholm C: Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. / J Clin Invest 1998, 101:956鈥?0. CrossRef
43. Hegele RA, Harris SB, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW: Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. / Atherosclerosis 1999, 146:153鈥?0. CrossRef
44. Shohet RV, Vega GL, Anwar A, Cigarroa JE, Grundy SM, Cohen JC: Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. / Arterioscler Thromb Vasc Biol 1999, 19:1975鈥?.
45. Ruixing Y, Qiming F, Dezhai Y, Shuquan L, Weixiong L, Shangling P, Hai W, Yongzhong Y, Feng H, Shuming Q: Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and Han populations. / J Lipid Res 2007, 48:2673鈥?1. CrossRef
46. People's Republic of China--United States Cardiovascular and Cardiopulmonary Epidemiology Research Group: An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. / Circulation 1992, 85:1083鈥?6.
47. Paffenbarger RS, Wing AL, Hyde RT: Physical activity as an index of heart attack risk in college alumni. / Am J Epidemiol 1978, 108:161鈥?5.
48. Ruixing Y, Jinzhen W, Yaoheng H, Jing T, Hai W, Muyan L, Yiyang L, Dongmei F, Hanjun Y, Yuming C: Associations of diet and lifestyle with hyperlipidemia for middle-aged and elderly persons among the Guangxi Bai Ku Yao and Han populations. / J Am Diet Assoc 2008, 108:970鈥?. CrossRef
49. Ruixing Y, Weixiong L, Hanjun Y, Dezhai Y, Shuquan L, Shangling P, Qiming F, Jinzhen W, Jianting G, Yaju D: Diet, lifestyle, and blood pressure of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations. / Am J Hypertens 2008, 21:382鈥?. CrossRef
50. Ruixing Y, Shangling P, Shuquan L, Dezhai Y, Weixiong L, Qiming F, Yuming C, Yaoheng H, Yijiang Z, Qinchen L: Comparison of hypertension and its risk factors between the Guangxi Bai Ku Yao and Han populations. / Blood Press 2008, 17:306鈥?6. CrossRef
51. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC: Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC). / J Lipid Res 1998, 39:228鈥?2.
52. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD: Hepatic lipase and dyslipidemia: interactionsamong genetic variants, obesity, gender, and diet. / J Lipid Res 2003, 44:1279鈥?6. CrossRef
53. Zambon A, Deeb SS, Bensadoun A, Foster KE, Brunzell JD: In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. / J Lipid Res 2000, 41:2094鈥?.
54. Deeb S, Peng R: The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. / J Lipid Res 2000, 41:155鈥?.
55. Park HS, Yun YS, Park JY, Kim YS, Choi JM: Obesity, abdominal obesity, and clustering of cardiovascular risk factors in South Korea. / Asia Pac J Clin Nutr 2003, 12:411鈥?.
56. Jenkins DJ, Kendall CW, Axelsen M, Augustin LS, Vusksan V: Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. / Curr Opin Lipidol 2000, 11:49鈥?6. CrossRef
57. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects of soy protein intake on serum lipids. / N Engl J Med 1995, 333:276鈥?2. CrossRef
58. Tomotake H, Yamamoto N, Yanaka N, Ohinata H, Yamazaki R, Kayashita J, Kato N: High protein buckwheat flour suppresses hypercholesterolemia in rats and gallstone formation in mice by hypercholesterolemic diet and body fat in rats because of its low protein digestibility. / Nutrition 2006, 22:166鈥?3. CrossRef
59. Ludvik BH, Mahdjoobian K, Waldhaeusl W, Hofer A, Prager R, Kautzky-Willer A, Pacini G: The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study. / Diabetes Care 2002, 25:239鈥?0. CrossRef
60. Adaramoye OA, Achem J, Akintayo OO, Fafunso MA: Hypolipidemic effect of Telfairia occidentalis (fluted pumpkin) in rats fed a cholesterol-rich diet. / J Med Food 2007, 10:330鈥?. CrossRef
61. Ren HY, Sun HG, Ma JZ, Zhang Y, Yi CR, Wu MX, Liu WL, Li GL: Experimental study on the effects of hemp fruit oil on serun lipid levels and lipid peroxidation. / Chin J Tradit Med Sci Technol 1997, 4:200.
62. Ren HY, Sun HG, Zhang Y, Yi CR, Wu MX, Li GL, Liu WL: Lipid-lowering and antiatherosclerotic effects of hemp fruit oil in partridges. / Henan Tradit Chin Med 1998, 18:294鈥?. - 作者单位：Li Meng (1)
Yin Ruixing (1)
Li Yiyang (1)
Long Xingjiang (1)
Li Kela (1)
Liu Wanying (1)
Zhang Lin (1)
Lin Weixiong (2)
Yang Dezhai (2)
Pan Shangling (3)
1. Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, 22 Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China
2. Department of Molecular Biology, Medical Scientific Research Center, 22 Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China
3. Department of Pathophysiology, School of Premedical Sciences, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China
文摘
Background The association between -250G>A polymorphism in the promoter region of the hepatic lipase gene (LIPC) and plasma high-density lipoprotein cholesterol (HDL-C) concentration is contradictory in diverse ethnics. Bai Ku Yao is an isolated subgroup of the Yao minority in China. This study was designed to detect the association of LIPC -250G>A (rs2070895) polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Methods A total of 778 subjects of Bai Ku Yao and 648 participants of Han Chinese aged 15-80 were randomly selected from our previous stratified randomized cluster samples. Genotyping of the LIPC -250G>A was performed by polymerse chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and then confirmed by direct sequencing. Results The levels of serum total cholesterol (TC), HDL-C, low-density lipoprotein cholesterol (LDL-C) and apolipoprotein (Apo) AI were lower in Bai Ku Yao than in Han (P < 0.01 for all). The frequencies of GG, GA and AA genotypes were 50.0%, 43.3% and 6.7% in Bai Ku Yao, and 35.7%, 50.6% and 13.7% in Han (P < 0.01); respectively. The frequencies of G and A alleles were 71.7% and 28.3% in Bai Ku Yao, and 61.0% and 39.0% in Han (P < 0.01). The levels of HDL-C and the ratio of ApoAI to ApoB in Bai Ku Yao were lower in GG genotype than in GA or AA genotype (P < 0.05-0.01). The levels of TC, HDL-C, LDL-C and ApoB in Han were lower in GG genotype than in GA or AA genotype (P < 0.05-0.01). The levels of HDL-C and the ratio of ApoAI to ApoB in Bai Ku Yao, and the levels of HDL-C, LDL-C and ApoB in Han were correlated with genotype and/or allele (P < 0.05 for all). Serum lipid parameters were also correlated with age, sex, alcohol consumption, cigarette smoking, blood pressure, body weight, and body mass index in both ethnic groups. Conclusions The differences in the serum lipid profiles between the two ethnic groups might partly result from different genotypic frequency of LIPC -250G>A or different LIPC-enviromental interactions.